A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus
NCT ID: NCT00282971
Last Updated: 2019-04-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
354 participants
INTERVENTIONAL
2006-03-06
2008-02-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes
NCT00424411
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control
NCT00134147
This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus
NCT00418522
A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
NCT00437489
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes
NCT00136916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inhaled Insulin
Inhaled insulin plus oral therapy
Inhaled Insulin (Exubera)
Addition of inhaled insulin to pre-existing oral diabetes therapy.
Standard of Care
Standard of Care: All licensed diabetes drugs can be prescribed per discretion of investigators
Standard of Care
Standard of Care: All licensed diabetes drugs can be prescribed per discretion of investigators
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inhaled Insulin (Exubera)
Addition of inhaled insulin to pre-existing oral diabetes therapy.
Standard of Care
Standard of Care: All licensed diabetes drugs can be prescribed per discretion of investigators
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Failing two or more oral anti-diabetic agents
Exclusion Criteria
* Smoking
35 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ängelholms sjukhus
Ängelholm, , Sweden
Sodersjukhuset
Stockholm, , Sweden
Karolinska US Huddinge
Stockholm, , Sweden
Gain Medical Center
Coquitlam, British Columbia, Canada
Misericordia Health Centre
Winnipeg, Manitoba, Canada
Maritime Research Center
Bathurst, New Brunswick, Canada
Office of Dr. Salim Sunderji
London, Ontario, Canada
Orillia Soldier's Memorial Hospital
Orillia, Ontario, Canada
Douglas Tweel M.D. Professional Corporation
Charlottetown, Prince Edward Island, Canada
Laboratoire Sante Le Gaspesien Inc.
Bonaventure, Quebec, Canada
Centre de santé et de services sociaux de Chicoutimi, Centre de médecine genique communataire
Chicoutimi, Quebec, Canada
Rhodin Recherche Clinique
Drummondville, Quebec, Canada
Q & T Research Outaouais Inc.
Gatineau, Quebec, Canada
Hopital Charles LeMoyne
Greenfield Park, Quebec, Canada
Hopital Laval
Saint-Foy, Quebec, Canada
Centre Medical des Carrieres
Saint-Marc-des-Carrieres, Quebec, Canada
CIC Mauricie Inc.
Trois-Rivières, Quebec, Canada
Hotel Dieu CHU, Clinique d´Endocrinologie, Maladie Metaboliques, Nutrition
Nantes, Cedex 01, France
Groupe Hospitalier Sud/Service d'Endocrinologie
Amiens, , France
Private Practise
Armentières, , France
Service d'Endocrinologie-
Bondy, , France
Hopital LA Cavale Blanche, Service de Diabetologie
Brest, , France
CHU Cote de Nacre, Service d'Endocrinologie
Cean Cedex, , France
Private Practise
Chartres, , France
Office of Antoine Lemaire, MD
Lille, , France
Centre Hospitalier Bretagne Sud
Lorient, , France
Hopital Lapeyronnie Sce des Maladies
Montpellier, , France
Hopital Saint Michel
Paris, , France
Hopital Bichat, Service d'Endocrinology
Paris, , France
Hopital Robert Debre
Reims, , France
C.H. Sud, Diabetologie
Rennes, , France
Centre Hospitalier Victor Provo
Roubaix, , France
Hôpital Jeanne d'Arc - Dommartin les Toul
Toul, , France
General Hospital of Athens "Laikon", 1st Propedeutic University Internal Medicine Clinic
Athens, , Greece
"Hygeia" Diagnostic and Therapeutic Center of Athens, Diabetes Clinic
Athens, , Greece
"ATTIKON" University General Hospital, 2nd Propedeutic University Internal Medicine Clinic
Haidari, , Greece
Peripheral General Hospital of Nikaia "Ag. Panteleimon", Internal Medicine Department
Pireaus, , Greece
University General Hospital of Thessaloniki "A.H.E.P.A." 1st Propedeutic University Internal Medicin
Thessaloniki, , Greece
Hospital Infante D. Pedro
Aveiro, , Portugal
Hospitais da Universidade de Coimbra
Coimbra, , Portugal
Associação Protectora dos Diabéticos de Portugal
Lisbon, , Portugal
Serviço de Endocrinologia - Hospital de Egas Moniz
Lisbon, , Portugal
Hospital Geral de Santo António
Porto, , Portugal
Centro Hospitalar de Torres Vedras
Torres Vedras, , Portugal
Hospital Clinico Universitario de Santiago
Santiago de Compostela, A Coruña, Spain
Hospital de Conxo
Santiago de Compostela, A Coruña, Spain
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Mutua de Terrassa
Terrassa, Barcelona, Spain
Clinica Universitaria de Navarra
Pamplona, Navarre, Spain
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain
Hospital General Universitario de Alicante
Alicante, , Spain
Hospital de La Santa Creu I Sant Pau
Barcelona, , Spain
Hospital General Universitario Valle de Hebron
Barcelona, , Spain
Hospital Universitario Puerta de Hierro
Madrid, , Spain
Hospital 12 de Octubre
Madrid, , Spain
Hospital de Mostoles
Madrid, , Spain
Complejo Hospitalario Carlos Haya Hospital Civil - Pabellon C
Málaga, , Spain
Hospital Montecelo
Pontevedra, , Spain
Hospital Universitario La Fe
Valencia, , Spain
Hospital Clinico Universitario de Valencia
Valencia, , Spain
Hospital Clinico Universitario Lozano Blesa
Zaragoza, , Spain
Hacettepe University Medical School Department of Endocrinology
Ankara, , Turkey (Türkiye)
Istanbul University Istanbul Medical School, Department of Endocrinology
Istanbul, , Turkey (Türkiye)
Dokuz Eylul University Medical School, Department of Endocrinology
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EXACTA
Identifier Type: OTHER
Identifier Source: secondary_id
2005-003504-11
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
A2171063
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.